Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05909163 · ClinicalTrials.gov registry record
Spoken Discourse Biomarker of PD Cognitive Impairment
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 140
- Enrollment target
NCT05909163 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 140 participants.
The verdict
NCT05909163 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to identify unique profiles of speech and language changes that distinguish individuals with Parkinson's disease from adults without Parkinson's disease and individuals with Parkinson's disease with cognitive (e.g., memory, thinking skills) impairment from those without cognitive impairment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2023-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05909163
The ClinicalTrials.gov registry entry for NCT05909163 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05909163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05909163 about?
NCT05909163 is a clinical study titled "Spoken Discourse Biomarker of PD Cognitive Impairment". The purpose of this study is to identify unique profiles of speech and language changes that distinguish individuals with Parkinson's disease from adults without Parkinson's disease and individuals with Parkinson's disease with cognitive (e.g., memory, thinking skills) impairment from those without ...
What is the current status of trial NCT05909163?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2019-03-05. Estimated completion is 2023-02-15.
Who is sponsoring clinical trial NCT05909163?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.